| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A decade of machine learning-based predictive models for human pharmacokinetics: Advances and challenges
|
Danishuddin,
|
|
|
27 |
2 |
p. 529-537
|
artikel
|
| 2 |
Advances in understanding the role of P-gp in doxorubicin resistance: Molecular pathways, therapeutic strategies, and prospects
|
Mirzaei, Sepideh
|
|
|
27 |
2 |
p. 436-455
|
artikel
|
| 3 |
A mechanistic perspective, clinical applications, and phage-display-assisted discovery of TNFα inhibitors
|
Alizadeh, Ali Akbar
|
|
|
27 |
2 |
p. 503-518
|
artikel
|
| 4 |
An updated review of folate-functionalized nanocarriers: A promising ligand in cancer
|
Ebrahimnejad, Pedram
|
|
|
27 |
2 |
p. 471-489
|
artikel
|
| 5 |
Applications of innovative technologies to the delivery of antipsychotics
|
Bergonzi, Maria Camilla
|
|
|
27 |
2 |
p. 401-421
|
artikel
|
| 6 |
Calming the cytokine storm of COVID-19 through inhibition of JAK2/STAT3 signaling
|
Gajjela, Bharath Kumar
|
|
|
27 |
2 |
p. 390-400
|
artikel
|
| 7 |
Contents page
|
|
|
|
27 |
2 |
p. i-ii
|
artikel
|
| 8 |
Crystallographic landscape provides molecular insights into the modes of action of diverse ROR-γt modulators
|
Suri, Charu
|
|
|
27 |
2 |
p. 652-663
|
artikel
|
| 9 |
dbDNA™: An advanced platform for genetic medicines
|
Adie, Tom
|
|
|
27 |
2 |
p. 374-377
|
artikel
|
| 10 |
Designing small molecules for therapeutic success: A contemporary perspective
|
Maurer, Tristan S.
|
|
|
27 |
2 |
p. 538-546
|
artikel
|
| 11 |
Electron diffraction: Accelerating drug development
|
Hovestreydt, Eric
|
|
|
27 |
2 |
p. 371-373
|
artikel
|
| 12 |
Focal adhesion kinase inhibitors in the treatment of solid tumors: Preclinical and clinical evidence
|
Quispe, Patricia A.
|
|
|
27 |
2 |
p. 664-674
|
artikel
|
| 13 |
Integrating heterogeneous data to facilitate COVID-19 drug repurposing
|
Prieto Santamaría, Lucía
|
|
|
27 |
2 |
p. 558-566
|
artikel
|
| 14 |
Knowledge-based approaches to drug discovery for rare diseases
|
Alves, Vinicius M.
|
|
|
27 |
2 |
p. 490-502
|
artikel
|
| 15 |
Medicinal mushrooms: Clinical perspective and challenges
|
Panda, Sujogya Kumar
|
|
|
27 |
2 |
p. 636-651
|
artikel
|
| 16 |
Micro- and nanoformulations of paclitaxel based on micelles, liposomes, cubosomes, and lipid nanoparticles: Recent advances and challenges
|
Alavi, Mehran
|
|
|
27 |
2 |
p. 576-584
|
artikel
|
| 17 |
Multiple strategies for the treatment of invasive breast carcinoma: A comprehensive prospective
|
Agarwal, Shivangi
|
|
|
27 |
2 |
p. 585-611
|
artikel
|
| 18 |
Natural resorcylic acid lactones: A chemical biology approach for anticancer activity
|
Kuttikrishnan, Shilpa
|
|
|
27 |
2 |
p. 547-557
|
artikel
|
| 19 |
Paracelsus’ legacy in the faunal realm: Drugs deriving from animal toxins
|
Fischer, Thomas
|
|
|
27 |
2 |
p. 567-575
|
artikel
|
| 20 |
Selectivity aspects of activity-based (chemical) probes
|
Heinzlmeir, Stephanie
|
|
|
27 |
2 |
p. 519-528
|
artikel
|
| 21 |
Targeting regulated cell death (RCD) with small-molecule compounds in cancer therapy: A revisited review of apoptosis, autophagy-dependent cell death and necroptosis
|
Liu, Wei
|
|
|
27 |
2 |
p. 612-625
|
artikel
|
| 22 |
The aryl hydrocarbon receptor: A diagnostic and therapeutic target in glioma
|
Lim, Ting Xiang
|
|
|
27 |
2 |
p. 422-435
|
artikel
|
| 23 |
Toward the institutionalization of quantum computing in pharmaceutical research
|
Zinner, Maximillian
|
|
|
27 |
2 |
p. 378-383
|
artikel
|
| 24 |
Using computers to ESKAPE the antibiotic resistance crisis
|
da Silva, Thiago H.
|
|
|
27 |
2 |
p. 456-470
|
artikel
|
| 25 |
Vascular thiol isomerases: Structures, regulatory mechanisms, and inhibitor development
|
Liang, Chenghui
|
|
|
27 |
2 |
p. 626-635
|
artikel
|
| 26 |
Waiving intellectual property rights: Boom or bust for medical innovation?
|
Rake, Bastian
|
|
|
27 |
2 |
p. 384-389
|
artikel
|
Tijdschrift beschrijving